Variant report
Variant | esv3411199 |
---|---|
Chromosome Location | chr6:65184431-65186429 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs141413599 | chr6:65185922-65185923 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs559099217 | chr6:65185952-65185953 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs577414912 | chr6:65185961-65185962 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs3846796 | chr6:65186006-65186007 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs562174266 | chr6:65186145-65186146 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs147002065 | chr6:65186157-65186158 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs541780913 | chr6:65186174-65186175 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs189241403 | chr6:65186244-65186245 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs530626683 | chr6:65186299-65186300 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs116341884 | chr6:65186314-65186315 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs547624741 | chr6:65186316-65186317 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs374316622 | chr6:65186335-65186336 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs59130430 | chr6:65186352-65186353 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs546606580 | chr6:65186373-65186374 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs567939150 | chr6:65186418-65186419 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs535397893 | chr6:65186427-65186428 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs554752983 | chr6:65186428-65186429 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164920 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian cancer | 19835627 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Epilepsy | 20502679 | CNVD |
Dyslexia | 22102821 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:65185800-65187800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr6:65186000-65186200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr6:65186200-65187200 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |